Research Article
Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting
Table 1
Baseline characteristics of patients.
| | Patient number | | | Sex | | | Men | (61.8%) | | Women | (38.2%) | | Type of diabetes | | | Type 1 | (15.5%) | | Type 2 | (85.5%) | | Age (years), mean (±SD) | 66.7 (±9.59) | | Duration of diabetes (years), mean (±SD) | 18.1 (±13.29) | | HbA1c, mean (±SD) | 7.4% (±1.25) | | Insulinotherapy | (36%) | | High blood pressure | (61.8%) | | Dyslipidemia | (25%) | | Nephropathy | (27%) | | Macroangiopathy | (3.6%) | | Sleep apnea syndrome | (3.6%) |
|
|
|
